Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Wenkun Ma"'
Autor:
Liangliang Cao, Wanqun Xie, Wenkun Ma, Heng Zhao, Jiajia Wang, Zhuangzhuang Liang, Shuaiwei Tian, Baocheng Wang, Jie Ma
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundThe significant progress of immune therapy in non-central nervous system tumors has sparked interest in employing the same strategy for adult brain tumors. However, the advancement of immunotherapy in pediatric central nervous system (CNS)
Externí odkaz:
https://doaj.org/article/3b6db043e3bc40c5833b28e91980385b
Autor:
Liangliang Cao, Shuaiwei Tian, Wenkun Ma, Zhouwen Ni, Gang Tian, Yang Zhao, Qinhua Wang, Zhen Xu, Jiajia Wang, Zhuangzhuang Liang, Heng Zhao, Lingrui Yang, Baocheng Wang, Jie Ma
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundChildren are more susceptible to the higher rate of massive blood transfusion because of the less allowable blood loss and lower intraoperative tolerance to blood loss during the resection of brain tumors. The surgical concept of en bloc re
Externí odkaz:
https://doaj.org/article/5525eadbab824f6cbd24df1cc302bb94
Publikováno v:
Diagnostics, Vol 12, Iss 11, p 2780 (2022)
Background: Heart failure is a serious complication resulting from left ventricular remodeling (LVR), especially in patients experiencing acute anterior myocardial infarction (AAMI). It is crucial to explore the predictive parameters for LVR followin
Externí odkaz:
https://doaj.org/article/d1d39334a60c48b0b3e61a3e90add76e
Autor:
Zaili Luo, Mingyang Xia, Wei Shi, Chuntao Zhao, Jiajia Wang, Dazhuan Xin, Xinran Dong, Yu Xiong, Feng Zhang, Kalen Berry, Sean Ogurek, Xuezhao Liu, Rohit Rao, Rui Xing, Lai Man Natalie Wu, Siying Cui, Lingli Xu, Yifeng Lin, Wenkun Ma, Shuaiwei Tian, Qi Xie, Li Zhang, Mei Xin, Xiaotao Wang, Feng Yue, Haizi Zheng, Yaping Liu, Charles B. Stevenson, Peter de Blank, John P. Perentesis, Richard J. Gilbertson, Hao Li, Jie Ma, Wenhao Zhou, Michael D. Taylor, Q. Richard Lu
Publikováno v:
Nature. 612(7941)
Medulloblastoma (MB) is the most common malignant childhood brain tumor1,2, yet the origin of the most aggressive subgroup-3 form remains elusive, impeding development of effective targeted treatments. Previous analyses of mouse cerebella3,4or human